At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KVUE Kenvue Inc
Market Closed 05-15 16:00:00 EDT
17.11
-0.08
-0.47%
盘后17.14
+0.03+0.18%
19:52 EDT
High17.36Low16.98Vol22.14M
Open17.24D1 Closing17.19Amplitude2.24%
Mkt Cap32.78BTradable Cap32.78BTotal Shares1.92B
T/O378.51MT/O Rate1.16%Tradable Shares1.92B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Is It Time To Reconsider Kenvue (KVUE) After A 26% One-Year Share Price Decline
Simply Wall St.  ·  05-16 14:41
Is It Time To Reconsider Kenvue (KVUE) After A 26% One-Year Share Price Decline
BRIEF-Third Point Reports Share Stake in Meta, Dissolves In Alibaba, Microsoft
Reuters  ·  05-16 05:22
BRIEF-Third Point Reports Share Stake in Meta, Dissolves In Alibaba, Microsoft
BRIEF-Soros Fund Management Cuts Share Stake In Amazon, Tesla, Raises In Apple
Reuters  ·  05-16 05:13
BRIEF-Soros Fund Management Cuts Share Stake In Amazon, Tesla, Raises In Apple
Kenvue General Counsel Matthew Orlando disposes of 38,491 shares for $679,623.91
Reuters  ·  05-13
Kenvue General Counsel Matthew Orlando disposes of 38,491 shares for $679,623.91
Kenvue Inc. Stock Falls Monday, Underperforms Market
Dow Jones  ·  05-12
Kenvue Inc. Stock Falls Monday, Underperforms Market
Law firm Keller Postman appeals sanctions in Tylenol injury cases
Reuters  ·  05-11
Law firm Keller Postman appeals sanctions in Tylenol injury cases
Kenvue Deal Progress And Restructuring Raise New Questions For Investors
Simply Wall St.  ·  05-10
Kenvue Deal Progress And Restructuring Raise New Questions For Investors
UBS Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)
TIPRANKS  ·  05-08
UBS Sticks to Its Hold Rating for Kenvue, Inc. (KVUE)
Kenvue Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-07
Kenvue Inc reports results for the quarter ended March 31 - Earnings Summary
BRIEF-Kenvue Given Dynamic Nature Of Conditions Due To Middle East Conflict, Expect Continued Variability In Macroeconomic Environment- SEC Filing
Reuters  ·  05-07
BRIEF-Kenvue Given Dynamic Nature Of Conditions Due To Middle East Conflict, Expect Continued Variability In Macroeconomic Environment- SEC Filing
Kenvue: Given Dynamic Nature of Conditions Due to Middle East Conflict, Expect Continued Variability in Macroeconomic Environment- SEC Filing
THOMSON REUTERS  ·  05-07
Kenvue: Given Dynamic Nature of Conditions Due to Middle East Conflict, Expect Continued Variability in Macroeconomic Environment- SEC Filing
Kenvue: Impact of Issues Due to Middle East Conflict May Adversely Affect Prevailing Economic Conditions & Our Business - SEC Filing
THOMSON REUTERS  ·  05-07
Kenvue: Impact of Issues Due to Middle East Conflict May Adversely Affect Prevailing Economic Conditions & Our Business - SEC Filing
Kenvue 1Q Profit, Sales Climb as Turnaround Efforts Take Hold
Dow Jones  ·  05-07
Kenvue 1Q Profit, Sales Climb as Turnaround Efforts Take Hold
Kenvue Q1 revenue rises 4.5%, beats estimates
Reuters  ·  05-07
Kenvue Q1 revenue rises 4.5%, beats estimates
Kenvue FY26 Q1 diluted EPS rises 47% to $0.25; net sales increase 4.5% to $3.91 billion
Reuters  ·  05-07
Kenvue FY26 Q1 diluted EPS rises 47% to $0.25; net sales increase 4.5% to $3.91 billion
BRIEF-Kenvue Q1 Adjusted EPS USD 0.32
Reuters  ·  05-07
BRIEF-Kenvue Q1 Adjusted EPS USD 0.32
Kenvue Q1 EPS USD 0.25
THOMSON REUTERS  ·  05-07
Kenvue Q1 EPS USD 0.25
Kenvue Inc - Due to the Pending Transaction With Kimberly-Clark, the Company Will Not Be Providing Forward-Looking Guidance
THOMSON REUTERS  ·  05-07
Kenvue Inc - Due to the Pending Transaction With Kimberly-Clark, the Company Will Not Be Providing Forward-Looking Guidance
Kenvue Q1 Pretax Profit USD 672 Million
THOMSON REUTERS  ·  05-07
Kenvue Q1 Pretax Profit USD 672 Million
Kenvue Q1 Operating Income USD 767 Million
THOMSON REUTERS  ·  05-07
Kenvue Q1 Operating Income USD 767 Million
No data available

Introduction

Company Name.
Kenvue Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Issue price:
--